Among them, GPX8 showed mainly copy number heterozygous amplification in cancers such as ACC, LIHC and DLBC; while in cancers such as LUSC and ESCA, it mainly showed significant copy number heterozygous deletion. This evidence concerns the gene GPX8 and cancer.